{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:02:00Z","timestamp":1774054920962,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670505"],"award-info":[{"award-number":["81670505"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Shanghai Municipal Education Commission: Gaofeng Clinical Medicine grant support","award":["DLY201501"],"award-info":[{"award-number":["DLY201501"]}]},{"name":"the Three,year action plan for Shin Kang of Shanghai","award":["16CR3113B"],"award-info":[{"award-number":["16CR3113B"]}]},{"name":"Cross medical research fund of translational medicine, Shanghai Jiao Tong Universit","award":["ZHYXJCZDAL 190005"],"award-info":[{"award-number":["ZHYXJCZDAL 190005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Small bowel vascular malformation disease (SBVM) is the most common cause of obscure gastrointestinal bleeding (OGIB). Several studies suggested that EGFL6 was able to promote the growth of tumor endothelial cells by forming tumor vessels. To date, it remains unclear how EGFL6 promotes pathological angiogenesis in SBVM and whether EGFL6 is a target of thalidomide.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We took advantage of SBVM plasma and tissue samples and compared the expression of EGFL6 between SBVM patients and healthy people via ELISA and Immunohistochemistry. We elucidated the underlying function of EGFL6 in SBVM in vitro and by generating a zebrafish model that overexpresses EGFL6, The cycloheximide (CHX)-chase experiment and CoIP assays were conducted to demonstrate that thalidomide can promote the degradation of EGFL6 by targeting CRBN.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The analysis of SBVM plasma and tissue samples revealed that EGFL6 was overexpressed in the patients compared to healthy people. Using in vitro and in vivo assays, we demonstrated that an EMT pathway triggered by the EGFL6\/PAX6 axis is involved in the pathogenesis of SBVM. Furthermore, through in vitro and in vivo assays, we elucidated that thalidomide can function as anti-angiogenesis medicine through the regulation of EGFL6 in a proteasome-dependent manner. Finally, we found that CRBN can mediate the effect of thalidomide on EGFL6 expression and that the CRBN protein interacts with EGFL6 via a Lon N-terminal peptide.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Our findings revealed a key role for EGFL6 in SBVM pathogenesis and provided a mechanism explaining why thalidomide can cure small bowel bleeding resulting from SBVM.<\/jats:p>\n<\/jats:sec>","DOI":"10.1007\/s00018-020-03465-3","type":"journal-article","created":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T12:02:21Z","timestamp":1580558541000},"page":"5207-5221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Thalidomide targets EGFL6 to inhibit EGFL6\/PAX6 axis-driven angiogenesis in small bowel vascular malformation"],"prefix":"10.1007","volume":"77","author":[{"given":"Chao-Tao","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Yu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Lu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Zheng","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,1]]},"reference":[{"issue":"1","key":"3465_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.giec.2016.08.012","volume":"27","author":"CS Jackson","year":"2017","unstructured":"Jackson CS, Strong R (2017) Gastrointestinal angiodysplasia: diagnosis and management. Gastrointest Endosc Clin N Am 27(1):51\u201362","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"5","key":"3465_CR2","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.gie.2017.05.018","volume":"86","author":"A Becq","year":"2017","unstructured":"Becq A et al (2017) Hemorrhagic angiodysplasia of the digestive tract: pathogenesis, diagnosis, and management. Gastrointest Endosc 86(5):792\u2013806","journal-title":"Gastrointest Endosc"},{"key":"3465_CR3","doi-asserted-by":"publisher","first-page":"27280","DOI":"10.1038\/srep27280","volume":"6","author":"N Feng","year":"2016","unstructured":"Feng N et al (2016) HIF-1alpha and HIF-2alpha induced angiogenesis in gastrointestinal vascular malformation and reversed by thalidomide. Sci Rep 6:27280","journal-title":"Sci Rep"},{"issue":"10","key":"3465_CR4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/MCG.0000000000000260","volume":"49","author":"G Holleran","year":"2015","unstructured":"Holleran G et al (2015) Expression of angiogenic factors in patients with sporadic small bowel angiodysplasia. J Clin Gastroenterol 49(10):831\u2013836","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"3465_CR5","doi-asserted-by":"publisher","first-page":"1629-37.e1-4","DOI":"10.1053\/j.gastro.2011.07.018","volume":"141","author":"ZZ Ge","year":"2011","unstructured":"Ge ZZ et al (2011) Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation. Gastroenterology. 141(5):1629-37.e1-4","journal-title":"Gastroenterology."},{"issue":"5","key":"3465_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ceb.2010.08.010","volume":"22","author":"HM Eilken","year":"2010","unstructured":"Eilken HM, Adams RH (2010) Dynamics of endothelial cell behavior in sprouting angiogenesis. Curr Opin Cell Biol 22(5):617\u2013625","journal-title":"Curr Opin Cell Biol"},{"issue":"5","key":"3465_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1751-2980.2011.00506.x","volume":"12","author":"HH Tan","year":"2011","unstructured":"Tan HH et al (2011) The role of HIF-1, angiopoietin-2, Dll4 and Notch1 in bleeding gastrointestinal vascular malformations and thalidomide-associated actions: a pilot in vivo study. J Dig Dis 12(5):349\u2013356","journal-title":"J Dig Dis"},{"issue":"2","key":"3465_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1006\/geno.1999.6011","volume":"62","author":"G Yeung","year":"1999","unstructured":"Yeung G et al (1999) Cloning of a novel epidermal growth factor repeat containing gene EGFL6: expressed in tumor and fetal tissues. Genomics 62(2):304\u2013307","journal-title":"Genomics"},{"issue":"12","key":"3465_CR9","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1002\/cam4.1883","volume":"7","author":"Z Zhu","year":"2018","unstructured":"Zhu Z et al (2018) Elevated EGFL6 modulates cell metastasis and growth via AKT pathway in nasopharyngeal carcinoma. Cancer Med 7(12):6281\u20136289","journal-title":"Cancer Med"},{"issue":"12","key":"3465_CR10","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1038\/s41388-018-0565-9","volume":"38","author":"J An","year":"2019","unstructured":"An J et al (2019) EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis. Oncogene 38(12):2123\u20132134","journal-title":"Oncogene"},{"issue":"10","key":"3465_CR11","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1097\/01.tp.0000287596.91520.1a","volume":"84","author":"VR Mas","year":"2007","unstructured":"Mas VR et al (2007) Angiogenesis soluble factors as hepatocellular carcinoma noninvasive markers for monitoring hepatitis C virus cirrhotic patients awaiting liver transplantation. Transplantation 84(10):1262\u20131271","journal-title":"Transplantation"},{"issue":"25","key":"3465_CR12","doi-asserted-by":"publisher","first-page":"22035","DOI":"10.1074\/jbc.M110.187633","volume":"286","author":"SM Chim","year":"2011","unstructured":"Chim SM et al (2011) EGFL6 promotes endothelial cell migration and angiogenesis through the activation of extracellular signal-regulated kinase. J Biol Chem 286(25):22035\u201322046","journal-title":"J Biol Chem"},{"issue":"3","key":"3465_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cytogfr.2013.03.008","volume":"24","author":"SM Chim","year":"2013","unstructured":"Chim SM et al (2013) Angiogenic factors in bone local environment. Cytokine Growth Factor Rev 24(3):297\u2013310","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"3465_CR14","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1016\/j.celrep.2017.11.020","volume":"21","author":"K Noh","year":"2017","unstructured":"Noh K et al (2017) Differential effects of EGFL6 on tumor versus wound angiogenesis. Cell Rep 21(10):2785\u20132795","journal-title":"Cell Rep"},{"issue":"6168","key":"3465_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1244851","volume":"343","author":"J Kronke","year":"2014","unstructured":"Kronke J et al (2014) Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343(6168):301\u2013305","journal-title":"Science"},{"issue":"11","key":"3465_CR16","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.3748\/wjg.v22.i11.3158","volume":"22","author":"J Bauditz","year":"2016","unstructured":"Bauditz J (2016) Effective treatment of gastrointestinal bleeding with thalidomide\u2014chances and limitations. World J Gastroenterol 22(11):3158\u20133164","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3465_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1741-4520.2011.00351.x","volume":"52","author":"T Ito","year":"2012","unstructured":"Ito T, Handa H (2012) Deciphering the mystery of thalidomide teratogenicity. Congenit Anom (Kyoto) 52(1):1\u20137","journal-title":"Congenit Anom (Kyoto)"},{"issue":"5","key":"3465_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.blre.2015.03.003","volume":"29","author":"KM Kortum","year":"2015","unstructured":"Kortum KM et al (2015) Cereblon binding molecules in multiple myeloma. Blood Rev 29(5):329\u2013334","journal-title":"Blood Rev"},{"issue":"6168","key":"3465_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1126\/science.1244917","volume":"343","author":"G Lu","year":"2014","unstructured":"Lu G et al (2014) The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science 343(6168):305\u2013309","journal-title":"Science"},{"issue":"5","key":"3465_CR20","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1053\/j.gastro.2007.06.007","volume":"133","author":"GS Raju","year":"2007","unstructured":"Raju GS et al (2007) American Gastroenterological Association (AGA) Institute technical review on obscure gastrointestinal bleeding. Gastroenterology 133(5):1697\u20131717","journal-title":"Gastroenterology"},{"issue":"6","key":"3465_CR21","doi-asserted-by":"publisher","first-page":"e021385","DOI":"10.1136\/bmjopen-2017-021385","volume":"8","author":"CC Chang","year":"2018","unstructured":"Chang CC et al (2018) Validation of EGFL6 expression as a prognostic marker in patients with lung adenocarcinoma in Taiwan: a retrospective study. BMJ Open 8(6):e021385","journal-title":"BMJ Open"},{"issue":"7","key":"3465_CR22","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1200\/JCO.2006.08.8583","volume":"25","author":"RJ Buckanovich","year":"2007","unstructured":"Buckanovich RJ et al (2007) Tumor vascular proteins as biomarkers in ovarian cancer. J Clin Oncol 25(7):852\u2013861","journal-title":"J Clin Oncol"},{"issue":"6","key":"3465_CR23","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/mc.22985","volume":"58","author":"QW Zhang","year":"2019","unstructured":"Zhang QW et al (2019) EGFL6 promotes cell proliferation in colorectal cancer via regulation of the WNT\/beta-catenin pathway. Mol Carcinog 58(6):967\u2013979","journal-title":"Mol Carcinog"},{"issue":"5","key":"3465_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.7150\/ijms.18555","volume":"14","author":"CY Chuang","year":"2017","unstructured":"Chuang CY et al (2017) High level of plasma EGFL6 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma. Int J Med Sci 14(5):419\u2013424","journal-title":"Int J Med Sci"},{"issue":"12","key":"3465_CR25","doi-asserted-by":"publisher","first-page":"e52707","DOI":"10.1371\/journal.pone.0052707","volume":"7","author":"X Wang","year":"2012","unstructured":"Wang X et al (2012) Analysis of gene expression profiling in meningioma: deregulated signaling pathways associated with meningioma and EGFL6 overexpression in benign meningioma tissue and serum. PLoS One 7(12):e52707","journal-title":"PLoS One"},{"issue":"1","key":"3465_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ydbio.2011.06.045","volume":"358","author":"DC Darland","year":"2011","unstructured":"Darland DC et al (2011) Vascular endothelial growth factor (VEGF) isoform regulation of early forebrain development. Dev Biol 358(1):9\u201322","journal-title":"Dev Biol"},{"issue":"25","key":"3465_CR27","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1016\/j.febslet.2006.09.053","volume":"580","author":"BK Kim","year":"2006","unstructured":"Kim BK et al (2006) Neurogenic effect of vascular endothelial growth factor during germ layer formation of human embryonic stem cells. FEBS Lett 580(25):5869\u20135874","journal-title":"FEBS Lett"},{"issue":"7","key":"3465_CR28","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1167\/iovs.10-6726","volume":"52","author":"J Davis","year":"2011","unstructured":"Davis J, Piatigorsky J (2011) Overexpression of Pax6 in mouse cornea directly alters corneal epithelial cells: changes in immune function, vascularization, and differentiation. Invest Ophthalmol Vis Sci 52(7):4158\u20134168","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3465_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41419-019-1591-4","volume":"10","author":"DM Wu","year":"2019","unstructured":"Wu DM et al (2019) The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K\/AKT signaling. Cell Death Dis 10(5):349","journal-title":"Cell Death Dis"},{"issue":"1","key":"3465_CR30","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1038\/s41467-018-04600-2","volume":"9","author":"Y Nemlich","year":"2018","unstructured":"Nemlich Y et al (2018) ADAR1-mediated regulation of melanoma invasion. Nat Commun 9(1):2154","journal-title":"Nat Commun"},{"issue":"15","key":"3465_CR31","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1182\/blood-2011-11-394882","volume":"121","author":"I Nikolic","year":"2013","unstructured":"Nikolic I et al (2013) EGFL7 ligates alphavbeta3 integrin to enhance vessel formation. Blood 121(15):3041\u20133050","journal-title":"Blood"},{"key":"3465_CR32","doi-asserted-by":"crossref","unstructured":"Stankovic ND et al (2018) EGFL7 enhances surface expression of integrin alpha5beta1 to promote angiogenesis in malignant brain tumors. EMBO Mol Med 10(9)","DOI":"10.15252\/emmm.201708420"},{"issue":"1","key":"3465_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/jcp.24684","volume":"230","author":"SM Chim","year":"2015","unstructured":"Chim SM et al (2015) EGFL7 is expressed in bone microenvironment and promotes angiogenesis via ERK, STAT3, and integrin signaling cascades. J Cell Physiol 230(1):82\u201394","journal-title":"J Cell Physiol"},{"key":"3465_CR34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3389\/fgene.2018.00705","volume":"9","author":"L Jin","year":"2018","unstructured":"Jin L et al (2018) Fibroblast growth factor 10 and vertebrate limb development. Front Genet 9:705","journal-title":"Front Genet"},{"issue":"3\u20134","key":"3465_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.18632\/genesandcancer.11","volume":"5","author":"IC Lien","year":"2014","unstructured":"Lien IC et al (2014) Internal ribosome entry site of bFGF is the target of thalidomide for IMiDs development in multiple myeloma. Genes Cancer 5(3\u20134):127\u2013141","journal-title":"Genes Cancer"},{"issue":"7559","key":"3465_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nature14610","volume":"523","author":"J Kronke","year":"2015","unstructured":"Kronke J et al (2015) Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS. Nature 523(7559):183\u2013188","journal-title":"Nature"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03465-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-020-03465-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03465-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T00:22:38Z","timestamp":1612052558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-020-03465-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":36,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3465"],"URL":"https:\/\/doi.org\/10.1007\/s00018-020-03465-3","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,1]]},"assertion":[{"value":"10 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors disclose no conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All patients were provided informed consent by the Biomedical Ethics Committee of Renji Hospital. We also have obtained an IRB prior to taking human samples and our experiment was allowed by The Shanghai Research Center for Model Organisms Animal Care and Use Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}